Phillips Kathryn A, Douglas Michael P
Department of Clinical Pharmacy, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco.
Philip R. Lee Institute for Health Policy, University of California San Francisco, San Francisco.
J Precis Med. 2018 Oct;4.
The market for next-generation sequencing technologies (NGS) has grown dramatically. Health care decision-makers need empirical evidence on market growth and future trends in order to develop appropriate strategies and policies, but little has been published about the nature and size of these trends. We provide a snapshot of market trends through 2020. We found rapid growth of clinical NGS - the global clinical NGS services market was $2.2 billion in 2015 and is forecast to reach $7.7 billion by 2020. The reproductive health NGS test market is the largest market followed by the oncology NGS test market. The largest market is for tests that sequence >50 genes but not the entire exome or genome. Markets are growing rapidly in countries outside of the US. Despite rapid NGS test growth, there are a number of key issues that will need to be addressed to facilitate appropriate future growth.
下一代测序技术（NGS）的市场已急剧增长。医疗保健决策者需要有关市场增长和未来趋势的实证依据，以便制定适当的战略和政策，但关于这些趋势的性质和规模，已发表的内容很少。我们提供了截至2020年的市场趋势概况。我们发现临床NGS迅速增长——2015年全球临床NGS服务市场为22亿美元，预计到2020年将达到77亿美元。生殖健康NGS检测市场是最大的市场，其次是肿瘤学NGS检测市场。最大的市场是针对对超过50个基因进行测序但不是对整个外显子组或基因组进行测序的检测。美国以外国家的市场正在迅速增长。尽管NGS检测增长迅速，但为促进未来的适当增长，仍有一些关键问题需要解决。
